IT-901
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
| 100mg | Ikhona evenkileni | 500 |
| 500mg | Ikhona evenkileni | 800 |
| 1g | Ikhona evenkileni | 1200 |
| Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
5 - [(2,4-Dimethoxy-1-naphthalenyl) methylene]dihydro-2-thioxo-4,6 (1H,5H) -pyrimidinedione
Ikhowudi yoncumo:
O=C(/C(C(N1)=O)=CC2=C3C=CC=CC3=C(OC)C=C2OC)NC1=S
Ikhowudi ye-InChi:
InChI=1S/C17H14N2O4S/c1-22-13-8-14(23-2)11(9-5-3-4-6-10(9)13)7-12-15(20)18-17( 24)19-16(12)21/h3-8H,1-2H3,(H2,18,19,20,21,24)
Isitshixo se-InChi:
JHOPCCOYRKEHQU-UHFFFAOYSA-N
Igama elingundoqo:
IT-901, IT901, IT 901, 1584121-99-2
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
"I-IT-901 yi-c-Rel Inhibitor Edibanisa iiPropati ze-Anticancer kwi-Hematologic Malignancies ngokuVimba i-NF-κB-Controlled Oxidative Stress Responses. I-IT-901 ivimbela ngokukhawuleza i-NF-κB subunit c-Rel. IT-901 igxininiswe i-graft-versus- isifo somkhosi ngelixa ugcina umsebenzi we-graft-versus-lymphoma ngexesha lokutshintshwa kwe-allogeneic Uvavanyo oluqhubekayo lwe-IT-901 kunyango lwe-B-cell lymphoma luveze iipropati ze-antitumor kwi-vitro kunye ne-vivo ngaphandle kwesithintelo kwi-NF-κB-exhomekeke kwi-lymphoma. I-901 ayizange inyuse amanqanaba e-oksijini esebenzayo kwi-leukocyte eqhelekileyo, ebonisa iimpawu zayo ezikhethiweyo zomhlaza we-IT-901 yi-agent yonyango ye-novel yokunyanga i-lymphoid tumors kunye nesifo esixutywe ne-host.
Ithagethi: NF-kB
